My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener 🏛️ Insiders
✓ Last Updated: Nov 16, 2026 • Verified SEC EDGAR, 13F & Cboe Data for 2027 RQD Quant Engine v6.2 Live

Hims & Hers Health Inc. (HIMS) — RQD Stock Rating Cockpit

$16.02 -6.04% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $15.82

Hims & Hers Health Inc. (HIMS) carries a Roarable Rating of D (Sell) with 49/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $3.76B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HIMS Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HIMS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-22, Hims & Hers Health Inc. (NYSE: HIMS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 49/100 at a spot price of $16.02 (-6.04% 1D, market cap $3.76B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 4/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, HIMS ranks #242 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HIMS compare to PRVA and OPCH in the Health Care sector?
▼

Within the Health Care sector (Medical/Nursing Services), HIMS carries a Roarable D (49/100 RQD), trailing P/E of 53.9x, gross margin of 73.8%, and ROIC of 8.4%. By comparison, PRVA (Privia Health Group Inc.) holds a C grade (63/100 RQD, P/E 122.6x, ROIC 10.5%, cap $3.15B) and OPCH (Option Care Health Inc.) posts a B grade (73/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.74B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while AVAH leads on capital efficiency (15.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HIMS?
▼

Per HIMS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001773751), Hims & Hers Health Inc. generated $2.35B in revenue (+59.0% YoY), $128.4M in net income, and $194.4M in free cash flow against $2.15B in total assets and $726.2M in total debt. Key quantitative strengths: Strong cash generator (73.8% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 HIMS TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY • HARD STOP-LOSS (SUP) • TARGET (RES) • WHY

Where to Enter $HIMS, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

🏆 RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP • $HIMS R/R 2.2 : 1 • RQD 49/100 (D)
$HIMS
Spot $16.02
1. GET IN (ENTRY)
$15.92–$16.10
2. HARD STOP (SUP)
$15.19 (-5.2%)
3. GET OUT (T1/T2)
$17.06 / $17.86
STOP-LOSS FLOOR (SUP $15.19): Hard stop sits 5.2% below spot to cap downside below key institutional support. If $HIMS closes a daily candle below $15.19, step aside.
PROFIT TARGETS (RES $17.06 / $17.86): Scale out 50% at T1 (+6.5%) and trail stop to breakeven for T2 (+11.5%).
Want this $HIMS sheet + Today's Top 3 Trades emailed free? Paper Trade $HIMS →
⚡ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked • Enter Email Below to Unblur #2 & #3 + Get $HIMS Sheet
#1 • $ANET R/R 2.6 : 1
Arista Networks Inc.
IN
$164.14
STOP
$154.80
OUT
$178.00
#2 • 🔒 LOCKED R/R 2.6 : 1
AI Liquid-Cooling Leader
Target: +8.81% to +15.06% | Stop: -5.73%
#3 • 🔒 LOCKED R/R 2.3 : 1
Cash-Flow Buyback Machine
Target: +6.22% to +10.48% | Stop: -4.52%
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $15.81 (-1.28%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 15/20 (B) • 8.3% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (49/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.4% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510049
2-of-3 Quant Analysts Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D+ · Rk D
Cash (15)Whales (5)SEC (14)Macro (4)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE-4.1% Base Target
$43 Bull$15 Base$12 Bear
📬 FREE HIMS RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HIMS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (49/100 Composite)
🔍 WHY HIMS SCORES 49/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+15/20 pts (31% of score)

SEC XBRL FY 2025 (10-K): 8.3% FCF Margin ($194.4M FCF) & 73.8% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (29% of score)

Altman Z-Score 3.95 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▼ #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (25.2) create a -16 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
57
Grade C$24.07-20.5% Next Q
Q2 (-2Q)
54
Grade C-$19.14+3.1% Next Q
Q3 (-1Q)
52
Grade C-$19.73-18.8% Next Q
Current
49
Grade D$16.02-5.4% Hist 90D α
Trajectory: C (57) → D (49)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a HIMS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While HIMS currently carries a cautious 49/100 (D) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Strong cash generator (73.8% gross margin)—profits are backed by real money, not accounting tricks.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($26.17) and Max Pain ($16.82) forces dealer call-delta covering toward $43.04.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HIMS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HIMS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMOVERSOLD (<32)
25.230 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.95>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
8 / 99-Pt Accounting
52-WEEK LASER RANGE8% OF RANGE
L: $14$16.02H: $41
1. Money & Cash Health● HEALTHY
Are profits real cash in the bank?

Real cash coming in backs up reported profits (73.8% gross margin and healthy balance-sheet cushion).

Factor Grade: BRQD 15 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

2-of-3 Quant Analysts Bullish on HIMS

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (75)

8.4% ROIC with 73.8% gross margin and 2.81% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (70)

Altman-Z 3.95 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (33)

16/40 institutional & smart-money positioning score with 4/20 macro alignment.

Bull Case: Why Buyers Like HIMS
  • ✓Strong cash generator (73.8% gross margin)—profits are backed by real money, not accounting tricks.
Bear Case: What Could Go Wrong
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Priced at 54x earnings—high expectations leave less room for a lukewarm quarter.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring HIMS)

  • ✓Walkthrough of HIMS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HIMS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -32.83%▼ SUPPORT BREAKDOWN
2026-11-22O $17.05H $17.05L $16.02C $16.02VOL 13.59M
$40.66$33.98$27.30$20.63$13.95RES $27.85SUP $25.54$16.022026-05-262026-07-132026-08-272026-10-132026-11-22
🏛️ GURU-GRADE VALUATION & FORENSIC ACCOUNTING ENGINE NO MOAT (COST > RETURN) (ROIC 8.4% vs WACC 6.6%)

HIMS Intrinsic Fair Value Line, Peter Lynch Corridor, Forensic Trio & Warning Signs

1-SECOND VISUAL VALUATION ANCHOR (COMPOSITE DCF + PETER LYNCH + GRAHAM)
Fair Value: $12.88 vs Spot $16.02
MODESTLY OVERVALUED (-24.4%)
Undervalued Zone (< $11) Fair Value Corridor ($11–$15) Overvalued (> $15)
$16
⚡ INTERACTIVE 10-YEAR DCF SANDBOX

Test Your Own HIMS Growth & WACC Assumptions

YOUR DCF TARGET
$20.17
5-Yr Annual FCF Growth Rate: 13.3%
Discount Rate (WACC Hurdle): 6.6%
Year-10 Terminal FCF Multiple: 16.0x
Margin of Safety: -24.4% vs $16.02 Full DCF Table →
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HIMS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
38.4%/yr Implied 5Y Growth

vs. +59.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HIMS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HIMS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HIMS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HIMS)

Health Care Rank #242 of 1015 ⚔️ PRVA vs HIMS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (HIMS vs. PRVA, OPCH, LFST, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Hims & Hers Health Inc. (HIMS) ranks #242 by composite RQD confidence (49/100, grade D) and #179 by equity capitalization ($3.76B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while AVAH leads on capital efficiency and profitability with 15.7% ROIC and 33.3% gross margin. OPCH currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with HIMS at 49/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HIMS ACTIVE
Hims & Hers Health Inc.
D 49/100 53.9x 73.8% 8.4% -6.04% $3.76B Benchmark Subject
PRVA
Privia Health Group Inc.
C 63/100 122.6x — 10.5% +0.37% $3.15B /prva-vs-hims →
OPCH
Option Care Health Inc.
B 73/100 23.0x 19.3% 11.9% -0.31% $4.74B /opch-vs-hims →
LFST
LifeStance Health Group Inc.
C 64/100 — — 1.2% -3.12% $5.07B /lfst-vs-hims →
AVAH
Aveanna Healthcare Holdings Inc.
D+ 56/100 — 33.3% 15.7% -1.34% $2.34B /avah-vs-hims →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001773751 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Hims & Hers Health Inc. (HIMS) reported GAAP revenue of $2.35B (+59.0% vs. FY2024 revenue of $1.48B , and +169.2% cumulative change since FY2023) , GAAP net income of $128.4M, operating cash flow of $300.0M, and free cash flow of $194.4M (+5.3% YoY). On the balance sheet, HIMS closed FY2025 with $2.15B in total assets against $726.2M in total debt (Altman Z-Score: 3.95, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $2.35B $128.4M $300.0M $194.4M $2.15B $726.2M
FY2024 (FY) 2024-12-31 $1.48B $126.0M $251.1M $184.6M $707.5M $103.9M
FY2023 (FY) 2023-12-31 $872.0M -$23.5M $73.5M $34.2M $3.81B $890.9M

3. HIMS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HIMS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-22, Hims & Hers Health Inc. (NYSE: HIMS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 49/100 at a spot price of $16.02 (-6.04% 1D, market cap $3.76B). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 4/20, and Executive Insider Alignment 11/20. Across 1015 tracked Health Care issuers, HIMS ranks #242 in composite RQD confidence.

How does HIMS compare to PRVA and OPCH in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), HIMS carries a Roarable D (49/100 RQD), trailing P/E of 53.9x, gross margin of 73.8%, and ROIC of 8.4%. By comparison, PRVA (Privia Health Group Inc.) holds a C grade (63/100 RQD, P/E 122.6x, ROIC 10.5%, cap $3.15B) and OPCH (Option Care Health Inc.) posts a B grade (73/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.74B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while AVAH leads on capital efficiency (15.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HIMS?

Per HIMS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001773751), Hims & Hers Health Inc. generated $2.35B in revenue (+59.0% YoY), $128.4M in net income, and $194.4M in free cash flow against $2.15B in total assets and $726.2M in total debt. Key quantitative strengths: Strong cash generator (73.8% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HIMS trading relative to its 50-day, 200-day, and 52-week technical levels?

HIMS last traded at $16.02 (-6.04% on volume of 13,590,363 shares), positioning the stock -38.78% below its 50-day simple moving average ($26.17) and -39.82% below its 200-day simple moving average ($26.62). Across its 52-week range of $13.74 to $40.99, HIMS sits at the 8.4% percentile with a 14-day RSI of 25.2 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($14.02 to $18.02).

ROARABLE RATING BRIEF • RQD 49/100 (D) ✓ SEC XBRL & RQD VERIFIED

HIMS — Hims & Hers Health Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Hims & Hers Health Inc. (HIMS) earns a live Roarable RQD composite score of 49/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $16.02 (-6.04% 1D, market capitalization $3.76B).

  • Fundamental Cash Engine (15/20): Anchored by return on invested capital (ROIC) of 8.4%, gross margin of 73.8%, operating margin of 4.5%, and free cash flow yield of 2.81%.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (4/20) + Forensic Balance Sheet (14/20): Incorporates a 1.05x equity beta, Altman Z-Score of 3.95, Piotroski F-Score of 8/9, and Debt/Equity of 1.25x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Hims & Hers Health Inc. Is a NYSE-listed issuer classified under the Health Care sector and the Medical/Nursing Services industry,. Gross margin is 73.8% per the market data, indicating a high-margin revenue base relative to operating margin of 4.5%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Hims & Hers Health Inc. (HIMS) reported $2.35B in annual revenue (up from $1.48B in FY2024, +59.0% YoY) and $128.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($872.0M revenue, -$23.5M net income) through FY2025, HIMS scaled operating cash flow to $300.0M and free cash flow to $194.4M, backed by $2.15B in total assets against $726.2M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D • RQD 49/100): Strong cash generator (73.8% gross margin)—profits are backed by real money, not accounting tricks. Free cash flow yield of 2.81% and institutional whale pillar of 5/20. With Fundamental Cash Engine at 15/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $13.74 – $40.99 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 53.9x trailing P/E and 37.7x EV/EBITDA against 4.5% operating margins and a 1.05x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream dependencies, downstream customers, and sector correlations beyond the Health Care sector and Medical/Nursing Services industry classification are — Investors should note that second-order ripple analysis cannot be performed from this dataset.

  • Key Question #1: Can HIMS sustain or expand its 4.5% operating margin and 8.4% ROIC against Medical/Nursing Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $2.35B and free cash flow of $194.4M, how will capital allocation balance growth reinvestment against $726.2M in total debt?
  • Key Question #3: How sensitive is HIMS's 45.3x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.05x)?

HIMS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Hims & Hers Health Inc. (HIMS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HIMS Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HIMS Bull vs. Bear Conversation Board — What's Your Call at $16.02?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HIMS 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HIMS:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH 🎯 Target: $33.49 (+21.0%)
📌 Pinned Debate

Revenue expanded from $872.0M in FY 2023 to $2.35B in FY 2025 while operating income turned positive to $105.6M, with a Piotroski F-S

Revenue expanded from $872.0M in FY 2023 to $2.35B in FY 2025 while operating income turned positive to $105.6M, with a Piotroski F-Score of 8 out of 9.. When you look under the hood at HIMS, Fundamental Cash Engine is 15/20 with 73.8% gross margins and 8.4% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (10/20) has been quietly accumulating below $48.34. My 12M target is $33.49.

SectorRotator 🐂 BULL

@ShortSeller_Dan Fair point on 53.9x trailing P/E, but you're ignoring the forward operating leverage in Medical/Nursing Services. If gross margin (73.8%) holds, EPS grows into the multiple faster than bears think.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $22.70 (-18.0%)
Spot @ $27.68

A P/E (TTM) of 53.9 and EV/EBITDA of 37.7 sit against an FCF yield of only 2.81%, and debt climbed to $726.2M in FY 2025 from $103.9M i

Here is the bear case nobody on the bull side wants to address on HIMS: A P/E (TTM) of 53.9 and EV/EBITDA of 37.7 sit against an FCF yield of only 2.81%, and debt climbed to $726.2M in FY 2025 from $103.9M in FY 2024.. At 53.9x trailing P/E, even a small guidance miss in Medical/Nursing Services triggers a 12-15% air pocket.

🎯 DAILY PRE-BELL WATCHLIST • ENTRY, HARD STOP & TARGET EDUCATIONAL LEVELS ONLY • EVERY TRADE CARRIES RISK

3 Stocks on Our Radar Today — Entry, Hard Stop & Why

📊 Recent Paper Examples (Not Typical Real-Money Results): $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
TRADE #1 OF THE DAY R/R 2.6 : 1 • RQD 88 (A+)
$ANET Arista Networks Inc.
LONG (BUY SETUP)
1. Get In (Entry)
$164.14
2. Hard Stop
$154.80 (-5.7%)
3. Get Out (T1/T2)
$178.00 / $188.50
Entry Rule: Buy between $162.50 – $165.00 (or on 15-min candle reclaim above $165.40)
Stop Logic: Hard stop at $154.80 sits beneath the 50-day institutional demand shelf and October accumulation base—capping downside at -5.69% while targeting $178.00 to $188.50 (+14.84%).
4. Why Now: Microsoft (+6.68%) and Amazon (+6.12%) just surged while confirming $320B+ in data-center CapEx, yet passive ETF rebalancing pushed ANET down -2.79% to $164.14. Arista owns the 64.1% gross-margin 800G/1.6T back-end AI Ethernet switching monopoly that cashes those exact hyperscaler checks.
Horizon: 4–10 Trading Days (Supply-Chain Contagion Mean-Reversion Swing) Trade $ANET in $100K Arena →
TRADE #2 OF THE DAY R/R 2.6 : 1 • RQD 86 (A)
🔒 Setup #2: 130kW Direct-to-Chip Liquid Cooling & CDU Thermal Monopoly Pullback
LONG (BUY SETUP)
• Target Upside: +8.8% (T1) to +15.1% (T2)
• Max Downside Stop: -5.7% Hard Floor (2.6 : 1 R/R)
Order book sold out through 2027 on key VWAP support. Enter your email below for the ticker, buy trigger, and stop.
TRADE #3 OF THE DAY R/R 2.3 : 1 • RQD 85 (A)
🔒 Setup #3: 13.27x Forward P/E Money-Center Infrastructure Debt Underwriting Breakout
LONG (BUY SETUP)
• Target Upside: +6.2% (T1) to +10.5% (T2)
• Max Downside Stop: -4.5% Hard Floor (2.3 : 1 R/R)
Big-bank infrastructure lender breaking out with a -4.5% stop floor. Enter your email below for the entry zone and target.
Horizon: 5–12 Trading Days (Relative-Strength Financials Breakout)
⚡ See Setups #2 & #3 Right Now + Tomorrow's 3 Setups at 8:00 AM ET
Free impersonal market research. Educational levels only — past setups include losing stops and carry real risk of loss.
2. Guru Strategy Screeners, Formula Hub & Head-to-Head Battles
4. Editorial Investigations, FRED Macro & Interactive Tools
LIVE TAPE